Nvidia stock slips as CEO says China H200 go-ahead will show in purchase orders

Nvidia stock slips as CEO says China H200 go-ahead will show in purchase orders

New York, Jan 6, 2026, 16:21 EST — After-hours

  • NVDA down about 0.5% after hours; traded $186.84–$192.13 in the regular session
  • CFO says U.S. officials are “working feverishly” on export licenses for H200 shipments to China
  • Nvidia says its next-gen Rubin platform is in full production; partner systems due in 2H 2026

Nvidia (NVDA) shares dipped in after-hours trading on Tuesday after CEO Jensen Huang said purchase orders, not a public declaration, would signal when Chinese customers can buy the company’s H200 data-center AI chip, a predecessor to its current flagship Blackwell products. The stock was down 0.5% at $187.32, after moving between $186.84 and $192.13 in the regular session. Reuters

The update puts the spotlight back on China, where sales of top-end accelerators depend on U.S. export licenses — government approvals to ship. CFO Colette Kress said officials were “working feverishly” on applications and Nvidia still does not know when approvals will land, after President Donald Trump last year reversed a ban on shipping advanced AI chips to China. Nvidia has called for $500 billion in sales from its current Blackwell generation and the forthcoming Rubin chips by the end of the year, she added. MarketScreener

Nvidia used CES to sketch its next step after Blackwell, launching the Vera Rubin platform that pairs a new Vera CPU and Rubin GPU with networking and security chips, the company said. Nvidia said Rubin could reduce inference token cost — what it costs to generate each chunk of text or data in an AI response — by up to 10 times and train mixture-of-experts models, which route requests to specialist sub-models, using about a quarter of the GPUs versus Blackwell. Rubin-based products will be available from partners in the second half of 2026, Nvidia said. NVIDIA Newsroom

Huang also argued that the next generation would ease data center cooling, saying “no water chillers are necessary for data centres.” The remark knocked shares of Johnson Controls and Trane, two companies that sell cooling equipment into data centers. Barclays analyst Julian Mitchell wrote that “one should not take their comments lightly,” given Nvidia’s influence across the AI supply chain. Reuters

Nvidia and Siemens announced an expanded partnership to build what they called an industrial AI operating system, aimed at speeding up design, simulation and factory operations. The companies said they plan to start in 2026 with a blueprint site at Siemens’ electronics factory in Erlangen, Germany, using Nvidia’s Omniverse software and AI infrastructure. NVIDIA Newsroom

Investors are also watching how fast rivals such as Advanced Micro Devices can close the gap in data center accelerators, and whether large cloud customers lean more on in-house chips. If Rubin shifts spending toward networks and storage as well as GPUs, that could ripple across suppliers.

For Nvidia stock, the near-term catalyst is concrete: export-license approvals and purchase orders that show whether H200 shipments can restart at volume. Traders will also look for signals that Blackwell supply and pricing remain firm as big customers plan next-wave data center builds.

But license delays or a change in U.S. policy would push out China revenue and complicate inventory planning. The efficiency claims around Rubin and data center cooling are still targets, and customers will need to validate them at scale.

Nvidia’s next scheduled update is its fourth-quarter fiscal 2026 results on Feb. 25. Investors will look for guidance on China shipments, Blackwell demand and the timing of early Rubin deployments. Nvidia

Stock Market Today

  • Lilly to buy Ventyx Biosciences for $1.2 billion as obesity-pill bets sharpen
    January 7, 2026, 5:16 PM EST. Eli Lilly shares rose after it agreed to buy Ventyx Biosciences for $1.2 billion, expanding beyond diabetes and weight-loss drugs. Lilly closed up 4.1% at $1,108.09, after touching $1,117.37, valuing the company near $1 trillion. The cash offer of $14 a share is a 62% premium to Ventyx's 30-day VWAP (volume-weighted average price); Lilly expects closing in H1 2026, pending votes and regulators; about 10% of Ventyx shares have signed support. Lilly's research chief Daniel Skovronsky cited inflammation as a disease driver; Ventyx CEO Raju Mohan called the tie a strategic fit. The broader market was mixed: S&P 500 down, Dow lower, Nasdaq up ahead of payrolls data. Nimbus Therapeutics struck an AI-enabled obesity collaboration with Lilly; Lilly also eyes Aktis Oncology's IPO.
Tesla stock slides 4% as Germany, UK sales data flag Europe pressure ahead of earnings
Previous Story

Tesla stock slides 4% as Germany, UK sales data flag Europe pressure ahead of earnings

Micron stock jumps 10% as Nvidia CES comments push MU to fresh highs
Next Story

Micron stock jumps 10% as Nvidia CES comments push MU to fresh highs

Go toTop